Protagenic Therapeutics, Inc. (PTIX)
OTCMKTS · Delayed Price · Currency is USD
0.8100
+0.0862 (11.91%)
At close: Apr 24, 2026
Protagenic Therapeutics Market Cap
Protagenic Therapeutics has a market cap or net worth of $1.76 million as of April 28, 2026.
Market Cap
1.76M
Enterprise Value
3.54M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.81
Market Cap Chart
Since May 19, 2025, Protagenic Therapeutics's market cap has decreased from 9.64M to 1.76M, a decrease of -81.77%. That is a compound annual growth rate of -83.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 1.47M | -41.71% |
| Dec 31, 2025 | 2.52M | -73.91% |
| May 19, 2025 | 9.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Agentix | 1.76M |
| ZyVersa Therapeutics | 1.70M |
| Clearside Biomedical | 1.62M |
| inTerra Resources | 1.47M |
| Neon Bloom | 1.46M |
| Sirona Biochem | 1.35M |
| CERo Therapeutics Holdings | 1.30M |
| Lyra Therapeutics | 1.26M |